UROONCO PCa associate editor Assoc. Prof. Paweł Rajwa (PL) talks to Assoc. Prof. Roderick van den Bergh (NL) and Assoc. Prof. Juan Gómez Rivas (ES) on active surveillance in prostate cancer. This interview explores patient selection, evolving diagnostic approaches, and future trends shaping clinical decision-making and patient-centered care in 2026. The experts examine current practices and future directions in active surveillance for prostate cancer. Topics include optimal patient selection, the role of MRI and PSA, risk stratification, follow-up protocols, and transitioning to watchful waiting. Experts also discuss emerging tools such as AI and genomics, emphasizing individualized care, quality of life, and the need to reduce overtreatment while maintaining strong oncological outcomes.
